Optimizing Your Clinical Trial to Commercialization Journey

What if you could eliminate avoidable delays and have a seamless transition from clinical trials to commercialization when launching your new drug?

The challenges of handling and delivering highly potent oncology drugs

As the R&D in oncological therapies continues to grow, so does demand for the specialist manufacturing, packaging and distribution of such products whether they contain highly potent actives or are biological in nature.

Bridging the Gap

Quality Assured: How PCI Pharma Services helps to bring life-changing therapies to patients

Trends Driving Opportunities & Outsourcing

With the technologies needed to handle today’s complex therapies, such as biologics, highly potent drugs, and specialty drugs in patient-centric delivery systems, Contract Development and Manufacturing Organizations (CDMOs) such as PCI...

CDMOs Step Up Parenteral Manufacturing Support

Throughout the pandemic, CDMOs of all sizes and capabilities stepped in to fulfil industry needs, providing the capabilities and capacities for the manufacture of essential medicines.

EXECUTIVE INTERVIEW: Broadening Our Biologics Footprint, Together

At the end of 2021, PCI Pharma Services acquired Lyophilization Services of New England, Inc. (LSNE), expanding PCI’s breadth of services as a global CDMO, building on its expertise in specialty manufacturing and packaging at both clinical and ...

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.